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Abstract
A wide variation of people with an impairment or disability requires a “special care den-
tistry” once their general manifestations directly act in the oral cavity. This target public 
is inserted into the following categories: neuromotor disability, sensory disability, mental 
disorder, infecto-contagious diseases, chronic systemic diseases, and systemic condi-
tions. Among the several oral illnesses found in these groups, periodontal diseases have 
been the most frequent, becoming a major challenge for the dental practitioners. Thus, 
we described the microbiological, histopathological, and clinical features of periodontal 
diseases in each “special health care needs” group. Advances in “Omic” technologies 
have suggested the application of molecular biology methods to assess the genomics 
(genes), proteomics (proteins), transcriptomics (mRNA), and metabolomics (metabolites) 
aspects of periodontal diseases. These researches aim to promote a better understanding 
of the mechanisms involved in the pathogenesis and in the identification of new bio-
markers of periodontal diseases that help in diagnosis of periodontal diseases and in tis-
sue responses after treatments of gingivitis and periodontitis. As an alternative therapy, 
some bioactive materials and photobiomodulation may be indicated once they strongly 
stimulate the periodontal tissue regeneration, attenuate the inflammatory processes, and/
or promote the reconstruction of the microstructure of the periodontium.
Keywords: periodontal diseases, special health care needs, “Omic” technologies, 
bioactive materials, photobiomodulation
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1. Introduction
The World Health Organization (WHO) estimates that there are more than one billion people in 
the world living with some form of impairment or disability, of whom nearly 200 million have 
considerable difficulties in functioning [1]. There is a growing proportion of people with disabili-
ties worldwide, and these are vulnerable groups in both developed and developing countries.
Currently, the National Organization on Disability (NOD), a private and nonprofit organiza-
tion, estimates that 54 million children and adults in the United States have one or more dis-
abilities, with 35 million Americans being severely disabled [2–4]. The proportion of children 
with disabilities is estimated to be 12.5 million or around 18% [3–5]. According to the estimated 
data by National Health and National Health and Nutrition Examination Survey (NHANES), 
46% of adults in the United States have periodontitis, and 8.9% have severe periodontitis [6].
The geopolitical and social plurality of states and regions in Brazil have shown the emerging 
need for effective public policies to meet the specific needs of this diversity. According to the 
Brazilian Institute of Geography and Statistics, 45.6 million Brazilian citizens (equivalent to 23.9% 
of the population) have some type of neuropsychomotor impairment as physical, sensory—
visual and auditory—and intellectual disabilities. Among these, 17.7 million people (6.7% of 
the population) have severe disability. The majority of this target public is found in urban 
areas and is aged between 15 and 64 years; further, the northeastern areas have a higher num-
ber of cities with at least one person with disability [7]. Hence, oral health care needs should 
be emphasized mainly for this target public due to high susceptibility to infection risks and 
great vulnerability to develop illnesses. Mental disorders associated or not with disabilities 
must also be considered in these individuals. In this condition, the familiar influence shall be 
taken into account for these groups once their human development directly depends on the 
good relationship among them.
Regarding children with developmental disorders, especially the autism spectrum disorder 
(ASD), attention-deficit/hyperactivity disorder (AD/HD), or specific learning disorder (LD), 
the field of “special care dentistry” is rapidly gaining recognition as a necessary service 
once they require oral health care needs at all times [8]. According to American Psychiatric 
Association (APA) [9], these disorders have relatively been growing due to the increase in 
birth rates and life expectancy of these individuals. Another relevant factor would be the 
ability or difficulty to perform their self-care, in particular, in the mouth, resulting in a nega-
tive impact of precarious oral conditions. The main oral signs and symptoms found in this 
target public include poor oral hygiene, dental caries, and severity of periodontal diseases 
(PD). High incidence of dental hypoplasia, traumatic lesion (factitious, iatrogenic, and acci-
dental), drug-induced gingival overgrowth, dental malocclusion, and tooth missing are also 
evidenced [8, 10]. It is important to highlight that the large dental loss of intact teeth is caused 
by the destruction of the collagen fibers of the periodontal ligament (PDL) and severe resorp-
tion of alveolar bone tissue from the persistent supra and subgingival and periopathogenic 
microbiota, recognized as periodontal disease [11]. Therefore, this disease is one of the most 
common oral chronic infections in people with special health care needs (SHCN), becoming 
an important dental public health problem.
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Based on combined data from the literature and our scientific experiences, we discussed the 
microbiological, histopathological, and clinical features of PD in each “special care needs” 
group. Furthermore, we reported some advances in “Omic” technologies which are molecular 
biology methods used to assess the genomics (genes), proteomics (proteins), transcriptomics 
(mRNA), and metabolomics (metabolites) aspects of PD. These methods promote a better 
understanding of the mechanisms involved in the etiopathogenesis and in the identification of 
new biomarkers of PD that help in the diagnosis of PD and in tissue responses after treatments 
of gingivitis and periodontitis. In addition, alternative therapies to PD in patients with SHCN 
were recommended in order to aggregate new scientific knowledge, some of them being inves-
tigated at the Center of Biosciences Applied to Persons with Special Care Needs (CEBAPE) of 
the Institute of Science and Technology of the São Paulo State University (UNESP).
2. Special Health Care Needs (SHCN) in dentistry
The field of “special care dentistry” is rapidly gaining recognition as a service that should 
be provided to persons with physical, mental, or intellectual disabilities by general physi-
cians, pediatric physicians, geriatric physicians, dental practitioners, and dental hygienists. 
Considering the limited opening of the oral cavity and the great difficulty of clinical procedure 
handling, the special needs patients may be treated under applying of psychological, physical, 
or pharmacological techniques in order to control their behavior and the voluntary or invol-
untary body movements. These patients may be affected by several comorbid physical ill-
nesses including diabetes mellitus, cardiovascular diseases, respiratory illnesses as aspiration 
pneumonia, sleep disturbance as obstructive sleep apnea, malignant neoplasms, and so on.
Extrinsic and intrinsic factors may corroborate to the installation and perpetuation of PD, as 
well as increase the susceptibility to supra and subgingival periopathogens in these individu-
als, even after oral hygiene promotion and/or intensive conventional mechanical treatment, 
combined or not with a supportive therapy. Concerning the main extrinsic factors, previous 
studies have considered oral mucositis-inducing chemotherapy drugs, saliva flow-reducing 
medications, respiratory disturbances as mouth breathing leading to oral hyperventilation 
and, as a consequence, dry mouth, motor deficit, cognitive impairment, learning difficulty 
and disability, crowded teeth, and inappropriate diet. The intrinsic factors include immune 
response deficiency, a high amount of periopathogens, sleep disorders such as obstructive 
sleep apnea, dysfunction of the oropharyngeal muscles resulting in severe dysphagia, and the 
risk of occurrence for aspiration pneumonia. Previous studies confirm the presence of respira-
tory pathogens in the oral cavity which may be aspirated into the lung alveoli due to severe 
dysphagia, developing aspiration pneumonia [12, 13]. This comorbidity may negatively 
influence the oral health homeostasis, aggravating the preexistent inflammatory processes, 
in particular, the PD.
Current researches confirm that the therapy applying neuromuscular electrical stimulation 
on the masticatory muscles was effective in adults with cerebral palsy. This biostimulating 
effect also reflected in the electrical activity of the oropharyngeal muscles, favoring their func-
tional performance; then, a positive effect on the apnea and hypopnea index was found. These 
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episode cascades reduced the number of pathological respiratory events, promoting improve-
ments in the quality of life for these patients [12–14].
Regarding the oral health status of these populations, the main oral manifestations are dental 
caries, dental hypoplasia, dental agenesis, orofacial traumas, drug-induced gingival over-
growth, and, in particular, PD [8]. Recent studies have shown that the presence of periodon-
topathic microbiota at the oral biofilm and/or spread throughout the saliva may explain the 
higher susceptibility to PD in this target public [15, 16].
According to the Joint Advisory Committee for Special Care Dentistry (JACSD), “special 
care dentistry” provides oral services for people with an impairment or disability including 
physical, sensory, intellectual, mental, medical, social, or a combination of one or more of 
these [17]. Several conditions, disorders, and/or disabilities lead these patients to the need 
of specialized oral assistance. In Brazil, the Federal Council of Dentistry has recognized the 
specialty of Dentistry for Patients with Special Health Care Needs as a dental service which 
has been assisting people with simple or complex disabilities, of acute or chronic nature, and 
temporary or permanent conditions or disorders. This target public is inserted into the follow-
ing categories: neuromotor disability (1), sensory disability (2), mental disorder (3), infecto-
contagious diseases (4), chronic systemic diseases (5), and systemic conditions (6).
The neuromotor disorders (1) include people with physical and intellectual disabilities which are 
from an unknown, environmental, and a genetic origin. These disorders consist of cerebral palsy, 
cerebrovascular disturbances (e.g., ischemic and hemorrhagic cerebral strokes), spinal cord 
injury, myelomeningocele, infectious disease (e.g., poliomyelitis or infantile paralysis), autoim-
mune diseases (e.g., myasthenia gravis and multiple sclerosis), muscular dystrophy resulting in 
muscle weakness and cellular degeneration, metabolic bone diseases (e.g., rachitis or osteoma-
lacia caused by genetic, nutritional and/or hormonal abnormalities affecting bone growth and 
remodeling), and bone genetic disorder (e.g., dysostosis, osteopetrosis and imperfect osteogen-
esis). The congenital and acquired abnormalities, resulting in craniomaxillofacial deformities, 
complex malformations, and syndromes are also included in the neuromotor disorders. It is 
important to emphasize that the intellectual disabilities may be associated with these conditions.
The sensory disorders (2) include the hearing and visual disabilities, generating immediate harm-
ful effects as depression, isolation, dementia, and decrease of quality of life [18]. The severity of 
these impairments may result in the disruption of interpersonal relations and decrease of self-
sufficiency in daily living activities, both of which are critical to the well-being of a person [19]. 
Hearing disability, with its resultant difficulties in communication function, pervades multiple 
domains of function in the individuals, decreasing activity, increasing depressive symptoms, 
and confounding assessment of cognitive ability. Although it is not curable, this impairment is 
often remediable with appropriate audiologic evaluation and the prescription of amplification 
devices. Visual disability also affects multiple domains of function, limiting the individuals’ 
ability and increasing the risk of falls, fractures, and morbidity. In order to attenuate the conse-
quences of visual disability, the cause must be identified to obtain an effective treatment [20].
Conforming to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5) published by the American Psychiatric Association (APA) under coordination of 
the Division of Mental Health of the World Health Organization (WHO) and the National 
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Institute of Mental Health (NIMH), a mental disorder (3) is a syndrome characterized by clini-
cally significant disturbances in an individual’s cognition, emotion regulation, or behavior 
which reflects a dysfunction in psychological, biological, or developmental processes under-
lying mental functioning [9]. Thus, mental disorders are usually associated with significant 
distress or disability in social, occupational, or other important activities. An expectable or 
culturally approved response to a common stressor or loss (e.g., the death of a loved one) is 
not considered a mental disorder [9]. For a better elucidation, the new North American clas-
sification of mental disorders is briefly mentioned in Figure 1.
Among the different groups of psychopathologies, it is worth mentioning the neurodevelopmen-
tal disorders which include intellectual disabilities (mild, moderate, and severe levels), autism 
spectrum disorder (ASD), attention deficit and hyperactivity disorder (ADHD), communication 
disorders (speech and language impairments), specific learning disorder, motor disorders (e.g., 
stereotyped movement disorder and tic disorders), and so on [9]. Children with neurodevelop-
mental disorders may experience difficulties with language and speech, motor skills, behavior, 
memory, learning, or other neurological functions [14]. While the symptoms and behaviors of 
neurodevelopmental disabilities often change or evolve as a child grows older, some disabilities 
are permanent. Diagnosis and treatment of these disorders may be difficult, frequently involving 
a combination of professional therapy, pharmaceuticals, and home- and school-based programs.
Considering the most common mental disorders including dementia, depression, generalized 
anxiety disorder, panic disorder, obsessive–compulsive disorder, posttraumatic stress, and 
phobias, the psychiatric patients have presented high susceptibility to PD. These illnesses 
have been caused by a set of processes such as the presence of oral microbial biofilm due 
to poor oral hygiene, psychotropic medication-induced dry mouth, and gingival hyperpla-
sia [15, 21]. Mental health clinicians should also be aware of the oral consequences of pre-
scribed medications, especially the antipsychotic drugs [15]. About this, the depression may 
dysregulate regulatory mechanisms within the brain involved in immune regulation, alter 
the immune system responses, and thereby influence the development and progression of 
infections and inflammatory diseases, including periodontitis [22]. As a support therapy, 
antidepressant drugs, such as fluoxetine, tianeptine (selective serotonin reuptake inhibitor), 
and venlafaxine (serotonin-norepinephrine reuptake inhibitor) are used; however, the side 
effects could affect the periodontal tissue health [23]. Current studies using animal models 
showed that the fluoxetine reduced the alveolar bone loss due to suppression of inflamma-
tory response and protection against periodontal bone resorption and collagen fibers destruc-
tion of the periodontal ligament (PDL), while the tianeptine influenced the immune system, 
enhancing the plasma concentrations of pro-inflammatory and T regulatory cytokines and 
interleukins in response to the gram-negative bacterial lipopolysaccharide (LPS) antigen. As 
a consequence of these processes, there is an inhibition of the periodontal disease progression 
[24, 25]. On the other hand, the venlafaxine influenced the increase of alveolar bone loss, most 
likely due to its anti-inflammatory and immunoregulatory effects on the periodontitis once it 
is considered an inflammatory disorder and an immunologically compromised disease [22].
Therefore, an increased focus on the physical health of psychiatric patients should encom-
pass oral health including closer collaboration between the dental practitioners and clini-
cians. Possible interventions must include the following approaches: to apply the best 
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practices in health care focusing the transdisciplinary, to remove first the infectious foci as 
oral microbial biofilm and dental calculus through dental scaling and root planning for an 
appropriate teeth cleaning and reduction or inactivation of periodontal pockets, to guide the 
regular use of dental floss or interdental brushes and tooth brushing, to insert monitoring 
processes on oral self-care such as to create a strategic planning on interdental cleaning 
Figure 1. Different condition groups of mental disorders described in the fifth edition of the diagnostic and statistical 
manual of mental disorders published by the American Psychiatric Association [9].
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behaviors according to the difficulty levels of learning and the motor and cognitive dysfunc-
tion of each individual, and to perform periodic oral appraisals for necessary methodologi-
cal adjustments in order to ensure the maintenance and the preservation of good oral health. 
Before introducing these procedures, the dental practitioner must comprehend the profile of 
each patient with SHCN, so as to know the physical and intellectual limitations, to identify 
the presence of comorbid diseases which may affect the overall health, and to assess the 
psychiatric behavior related to oral self-care. Surely, this systemic overview may favor the 
homeostasis of the stomatognathic system and improve the general health conditions, once 
these approaches can prevent the development of extensive and severe PD avoiding dental 
mobilities and/or loss.
The infecto-contagious diseases (4) is a subset category of highly dangerous transmissible 
diseases which include mainly infected patients with human immunodeficiency virus (HIV) 
infection and acquired immune deficiency syndrome (AIDS), patients with active tuberculo-
sis disease, patients with viral hepatitis, and other such patients.
The chronic systemic diseases (5) are illnesses that spread throughout the body, affecting 
multiple organs and body systems, which may evolve into comorbidities, complicating the 
diagnosis and, consequently, influencing the prognosis. Considering this concept, the dis-
eases imply juvenile rheumatoid arthritis, diabetes mellitus, congenital and acquired heart 
diseases, hematological diseases or disorders, chronic renal failure, autoimmune diseases 
(lichen planus, pemphigoid, pemphigus vulgar, erythema multiforme, lupus erythematosus, 
epidermolysis bullosa, etc.), vesiculobullous diseases, and so on.
The systemic conditions (6) are recognized as secondary factors that may modulate the 
disease initiation or progression rather than acting as primary etiological factors. These cir-
cumstances may affect the onset, progression, and treatment of such disease. Several patient 
types are included in these conditions, such as patients submitted to radiotherapy and che-
motherapy in the head and neck regions, patients who received an organ transplant, patients 
with medication-induced immunosuppression, and similar others that may affect the general 
health conditions of the individual.
To better comprehend the relation among the environmental, genetic, and social effects and 
a person, a diagram was elaborated showing the occurrence of diseases, conditions, and/
or disorders which may manifest during the life course of an individual. It is important to 
emphasize that these etiopathological factors may contribute to the development of one or 
more disabilities, leading to an acquired or congenital disability. On the other hand, an indi-
vidual may be born with one or more disabilitiy and, concomitantly, develop diseases or 
disorders due to the high susceptibility to the environment and the different levels of disabil-
ity complexity, characterizing the person with SHCN. It is noteworthy that the social impact 
resulting from precarious conditions of survival on the people with SHCN could explain the 
causes of health disparities or high occurrence of oral diseases (Figure 2). Socially disadvan-
taged groups have demonstrated poorer overall and oral health than the general population, 
becoming an aggravating factor, especially, in groups with SHCN. Therefore, a better atten-
tion to the public services in oral health for this population should be one of the main goals 
in government plans.
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2.1. Types of periodontal diseases in patients with SHCN
Some case reports of patients with SHCN were briefly described in relation to their clinical, 
radiographic, histopathological, and laboratorial characteristics together with the oral manifes-
tations, clinical procedures, and transdisciplinary approaches; then, we correlate them with the 
findings found in the literature. Furthermore, we mainly discuss the clinical management related 
to the PD. The additional commentaries are aimed to reinforce the importance of the early diag-
nosis and an appropriate dental treatment for each complexity of disability. Types of PD that 
were correlated with some categories of people with SHCN are depicted in the following section.
2.1.1. Case 1: chronic periodontitis associated with genetic disorder
 A 14-year-old adolescent girl with Robinow syndrome had low stature, mild exophthalmos, 
hyperthyroidism, frequent thrombocytopenia, splenomegaly, and genital abnormality such 
as hypoplastic clitoris and small lips (a). Esophageal reflux was reported in the initial years 
of life. Using the Nicodemo et al. [26] and Grenlieh-Pyle [27] methods, dental and bone ages 
were 11.4 and 12, respectively. The intraoral examination showed mouth respiration, angu-
lar cheilitis, dental malocclusion, and ulcerated gingival surface (b and c) and accentuated 
alveolar bone loss (d), especially, at the region of mandibular incisors. Histologically, gingi-
val tissues showed intense infiltration of mononuclear inflammatory cells diffusely spread 
throughout the connective tissue. Junctional epithelium hyperplasia with intense exocytosis 
(e) and extensive areas with no epithelium cover associated with infiltration of polymorpho-
nuclear inflammatory cells into the lamina propria were also evidenced. In addition, presence 
of bacterial colonies (black arrows) and necrotic alveolar bone tissue fragments (blue arrows) 
was found (f and g). The diagnosis was chronic periodontitis with ulceration areas (Image 1).
Figure 2. Diagram showing the life course of a susceptible individual to several extrinsic and intrinsic factors which may 
lead him/her to a disorder, disease, and/or a disability.
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2.1.2. Case 2: chronic gingivitis associated with genetic disorders plus uncommon 
abnormalities
A 19-year-old young man with Down syndrome associated with ectodermal anomalies. 
The extraoral features displayed dry skin and alopecia of eyelashes, eyebrows, and hair (a) 
while, the intraoral features showed dry mouth due to the severe reduction of saliva flow 
and mouth breathing, frequent angular cheilitis resulting from immune system deficiency, 
bilateral absence of the inner and upper third molars, presence of left upper and right lower 
deciduous canines, upper lateral incisors with microdontia, unerupted left upper permanent 
canine, generalized chronic gingivitis (a–d), and absence of caries. The recommended dental 
treatment was periodontal prophylaxis through the use of disclosing agents such as the scal-
ing and root planning (e–g). It is important to point out that oral hygiene orientation and 
diet control must be continuously performed because of the neuromotor dysfunction of these 
patients, resulting in great understanding difficulties and difficulties in handling of cleaning 
devices and leading to a poor oral hygiene. Concerning dental education, we consider that 
the learning for repetition and use of ludic techniques or resources are effective strategies 
which must be implemented by dental practitioners. We also suggest the saliva analysis to 
assess their physicochemical properties, to determine the susceptibility to stress measuring 
the concentrations levels of salivary amylase or cortisol, and to identify the occurrence risk 
for aspiration pneumonia using as a biomarker the Pseudomonas aeruginosa. It is important to 
highlight that patients with Down syndrome present immune system disorders; therefore, 
oral infections must be avoided for general health balance and maintenance (Image 2).
2.1.3. Case 3: severe medications-induced gingival overgrowth
A 11-year-old female child with West syndrome had multiple epileptic spasms and, as a 
consequence, a severe neuropsychomotor impairment. The electroencephalography showed 
a hypsarrhythmia pattern confirming the diagnosis. The recommended treatment to this 
Image 1. Chronic periodontitis associated with genetic disorder (hematoxylin–eosin; original magnifications 100 and 50×).
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condition has been the use of phenobarbital and/or valproic acid since birth. The intraoral 
features were drug-induced generalized gingival proliferative lesion with partial covering of 
the posterior teeth and gingival bleeding. Some permanent teeth were still impacted due to 
the presence of gingival fibrosis (a–c). The recommended dental therapy was the prophylactic 
periodontal treatment and gingivectomy (Image 3).
To illustrate this case, histopathological features were depicted in order to show the medica-
tion effects on the oral mucosa, in particular, on the gingival tissues (epithelium and connec-
tive tissue) (Figure 3).
2.1.4. Case 4: discreet chronic gingivitis associated with severe bruxism
A 7-year-old male child with spastic quadriplegic cerebral palsy, caused by hypoxic–ischemic 
brain damage, exhibited poor cognitive function and has been feeding on semi-solid food since 
3 years of age. Ranitidine hydrochloride was used to treat gastroesophageal reflux, and botu-
linum toxin was never used to decrease the severity of the sleep bruxism. As a consequence, 
severe upper and lower teeth wear reaching the region of the dental pulp were evidenced (a).
This child was in primary dentition phase and exhibited discreet chronic gingivitis, mouth-
breathing pattern, severe dysphagia, and involuntary tongue movements. First, oral hygiene 
orientation and diet control under supervision were done due to his severe neuromotor dys-
function. Posteriorly, we used a masticatory device denominated “hyperbola” to attenuate the 
sleep bruxism and, consequently, to improve the quality of his life. After the proposed therapy, 
we obtained satisfactory results, including reduction of the sleep bruxism and improvements 
of sucking-swallowing movements at meals. (Source: Giannasi, et al. [14]) (Image 4).
Image 2. Chronic gingivitis associated with genetic disorders plus ectodermal anomalies.
Periodontology and Dental Implantology264
Image 3. Severe medications-induced gingival overgrowth.
Figure 3. Medication-related gingival hyperplasia. Photomicrography showing gingival hyperplasia characterized by the 
epithelium hyperplasia and proliferation of dense connective tissue. Epithelial crest projections were thin and long (blue 
arrows), interconnecting them (black arrows) (a). A lamina propria exhibited infiltration of mononuclear inflammatory 
cells, especially lymphocytes, plasma cells, and macrophages. Furthermore, scattered eosinophilic globules of gamma 
globulin, known as Russell bodies (b; square), were also seen (hematoxylin–eosin; bars = 200 and 50 μm).
Image 4. Discreet chronic gingivitis associated with severe bruxism. (Source: Giannasi, et al. [14]).
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Image 5. Chronic gingivitis associated with visual disability and metabolic disease.
2.1.5. Case 5: chronic gingivitis associated with sensory disabilities and metabolic disease
A 9-year-old male child with visual disability resulting from the intracranial hypertension and/
or alterations in the vascularization of the optical nerves which were caused by the cystic cranio-
pharyngioma. Diabetes insipidus was developed as a complication of this disease, whereas, the 
motor functions, learning ability, memory, and mental health were preserved. The intraoral fea-
tures showed generalized chronic gingivitis and deep caries, in particular, in the molar regions, 
resulting from poor oral hygiene. Considering that the periodontal disease is one of the main oral 
complications of diabetes, the oral health balance must be a major goal of the dentists once hyper-
glycemic control in a diabetic child becomes is a great challenge for parents and doctor (Image 5).
2.1.6. Case 6: necrotizing periodontal disease associated with AIDS and metabolic disorder
A 59-year-old man with diagnosis of active positive-HIV had squamous cell carcinoma in 
the vestibular fornix region. In the clinical history, the patient was a smoker since the age 13 
and had arterial hypertension, saphenous bridge, and type 2 diabetes mellitus. The diagnosis 
of positive-HIV was confirmed when the patient was 36 years old. To treat the malignant 
neoplasm, chemotherapy and radiotherapy were indicated by the oncologists; however, no 
emergency dental treatment was done before the recommended therapies in order to first 
eliminate the dentoalveolar infection foci. We imply that the severe periodontitis combined 
with periapical lesion caused by the presence of residual root, quickly evolves into an abscess 
with spontaneous extraoral suppurative drainage. The neoplasm overgrowth and the indi-
cated therapies with no support dental treatment surely influenced this infectious process (a 
and b). Severe candidiasis was spread on the hard palate and, in particular, superior alveolar 
ridge (c). The exfoliative cytology confirmed the diagnosis, showing a great amount of Candida 
albicans hyphae (d) and indicating a highly immunocompromised patient. As a consequence 
of the oral condition, this patient was with a severe malnutrition and cachexia resulting in 
hypoglycemic shock and, then, progressing to his death in 15 days. Most likely, there was no 
favorable response to the medical therapeutic protocols due to the severity of the immuno-
suppression and the presence of generalized acute oropharyngeal infections (Image 6).
2.1.7. Case 7: generalized chronic periodontitis associated with heart and metabolic diseases
A 61-year-old man had uncontrolled and insulin-dependent type 2-diabetes mellitus, arte-
rial hypertension, ankylosing spondylitis, and hepatitis C. Regarding the diabetes control, 
the patient was treated with sinvastatina (10 mg), galvus (100 mg) and lantus (44 mL). The 
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glycated hemoglobin (HbA1c) value was 9.1% (Reference values: normal: ≤5,6%, prediabetes: 
5,7–6,4%, and diabetes mellitus: ≥6,5%, in accordance with the American Diabetes Association) 
[28]. In the intraoral features, generalized chronic periodontitis characterized by the clinical 
attachment loss and the periodontal abscess with suppurative drainage placed, in particular, 
at the right canine region were evidenced (a, b, c, and d). Oral hygiene was unsatisfactory, 
most likely because of the pain and the gingival bleeding stimulated by the use of cleaning 
devices. The periodontal treatment was done associated with prophylactic drugs as antibiot-
ics. No local vasoconstrictive anesthetic agent was administered during the clinical proce-
dures. (Courtesy: Professor Doctor Ana Cristina Solis) (Image 7).
Concerning the etiology of PD in patients with uncontrolled diabetes, the progressive attach-
ment loss was detected due to the function and reduction of polymorphonuclear leukocyte 
chemotaxis leading to an increase in infection susceptibility, collagen synthesis and matura-
tion reduction, increased collagenase activity, and the formation of advanced glycation end 
products (AGEs) that bind to the receptor for advanced glycation end products (RAGEs) in 
macrophages and monocytes. The effects of AGE accumulation increase tissue oxidant stress, 
alter the endothelial cell functions, elevate the activity of matrix metalloproteinases leading to 
the production of free radicals, and promote vascular dysfunction and cellular death. These 
factors may directly affect the migration and activity of inflammatory cells, impairing the 
mechanisms of defense against microorganisms and delaying the periodontal tissue repair 
processes, resulting in great losses of support structures [11].
To clarify these clinical findings, periodontal tissue alterations resulting from oral complica-
tions of diabetes were depicted, including intense alveolar bone resorption at the furcation 
region, proliferation of junctional epithelium (hyperplasia) toward the furcation, diffuse infil-
tration of mononuclear inflammatory cells which consisted of macrophages, lymphocytes, 
Image 6. Necrotizing periodontal disease in combination with AIDS and metabolic disorder (Papanicolaou stain, 
original magnification 400×).
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and especially plasma cells. Numerous blood vessels were congested and the diapedesis 
mechanism (leukocyte extravasation into connective tissue) were well evidenced, justifying 
the great amount of inflammatory cells at the lamina propria (Figure 4).
2.1.8. Case 8: autoimmune disease associated gingivitis (desquamative gingivitis)
A 33-year-old woman with chronic mucocutaneous inflammatory disorder of immunological 
background showing aggressive and extensive oral lesions with erythematous, erosive and 
extensive areas, especially in the marginal and attached gingivae (a and b). Histopathological 
features showing a band of infiltration of lymphocytic inflammatory cells under the surface 
epithelium extending throughout the gingiva (c), besides hydropic degeneration and sharp-
ness loss of the basal layer (d) (hematoxylin and eosin, 50× and 100×). The diagnosis was 
lichen planus. (Source: Gomes et al. [29]) (Image 8).
2.1.9. Case 9: gingivitis associated with hematological disorders
A 23-year-old young woman with Fanconi’s anemia had severe pancytopenia and a pro-
longed, long-term immunosuppression which resulted in the development of an abscess 
on the infra-orbicular region. This process progressed to phlegmon causing tissue necrosis 
of the nostrils, nasal septum, nasal fossa, and posterior orbit region of the right side (a). 
The etiologic agent of the phlegmon was Streptococcus parasanguinis. The myelogram shows 
moderately hypocellular bone marrow with cellular dysplasia involving the granulocytic, 
erythrocytic, and megakaryocytic (arrow) series (b). The intrabuccal examination showed 
abundant and spontaneous gingival bleeding, edema on the interdental papillae, hemato-
mas on the superior and inferior lips, and inadequate oral hygiene (c and d). No caries, 
alveolar bone loss, and periodontal pockets were evidenced. No bone marrow transplant 
was performed due to incompatibility of donors; thus, the only available option was an alter-
native treatment through the erythrocytes and platelets-concentrated transfusion to prevent 
Image 7. Generalized chronic periodontitis associated with heart and metabolic diseases. (Courtesy: Doctor Professor 
Ana Cristina Solis).
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spontaneous hemorrhages and severe anemia. Oral exfoliative cytology was performed, 
showing superficial epithelial cells with nuclear and cytoplasmic alterations, erythrocytes, 
bacterial colonies (cocci), and numerous hyphae and spores of Candida albicans (e). Based 
on this, drug administrations, as antifungal medication and antibiotics, were also indicated 
to treat the oral acute inflammatory processes caused by bacterial and fungal infections. 
It is important to emphasize that the dental interventions were done together to the rec-
ommended medical therapy until the disease remission period. Initially, the periodontal 
prophylaxis was carried out by dentist and, posteriorly, the orientation and control of oral 
hygiene and diet accomplished by nurses and caregivers after adequate training in oral 
health. The health multiprofessional team, who may participate in this treatment process, 
corroborated in favor of supportive health care, leading to a quick recovery time of the 
patient (Source: Gomes et al. [30]) (Image 9).
Figure 4. Photomicrography showing chronic periodontitis related to Case 7 (Masson’s trichrome; bars = 1000, 200, 100, 
and 50 μm).
Image 8. Gingivitis associated with autoimmune disease (desquamative gingivitis) (Source: Gomes et al. [29]).
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Image 10. Necrotizing ulcerative gingivitis associated with hematological disorder plus chemical and physical agents 
(Leishmann stain, 600×; Papanicolaou stain, 400×) (Source: Gomes et al. [31]).
2.1.10. Case 10: necrotizing ulcerative gingivitis associated with hematological disorder plus 
chemical and physical agents
A 14-year-old adolescent boy with Acute Lymphoblastic Leukemia (ALL) underwent the 
chemotherapy and radiotherapy on the region of the central nervous system for relapse pro-
phylaxis of the primary disease (a). The myelogram before the medical therapies displayed 
hypercellular bone marrow composed exclusively by lymphoblastic cells with numerous 
atypical mitoses (square) (b and c). Extra and intraoral features of the patient, before the rec-
ommended dental treatment, were acute necrotizing ulcerative gingivitis, severe oral muco-
sitis with areas necrosis associated to pseudomembranes, and facial asymmetry with signs of 
Image 9. Gingivitis associated with hematological disorders (Leishmann stain, 600×; Papanicolaou stain, 400×) (Source: 
Gomes et al. [30]).
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phlogistic processes (d and e). The exfoliative cytology of the hard palate and attached and 
free gingivae shows a great number of inflammatory polymorphonuclear and mononuclear 
cells, besides a great amount of Candida albicans hyphae confirming the diagnosis of candidia-
sis (f and g). The dental treatment protocol, inserted together to the medical therapies until the 
primary disease remission period, corroborated in favor of the patient’s general recovery time 
and of the elimination of the oral acute inflammatory process (h). The myelogram after the 
remission phase of the disease showed normal bone marrow (i and j). In extra- and intraoral 
features, the patient showed discreet facial asymmetry, discreet chronic gingivitis, and palate 
mucosae with normal features (l and m). Considering these clinical and histological findings, 
we dare reinforce that the insertion of a dental practitioner into the hospital transdisciplinary 
team is crucial to the medical therapy success and to the good quality of health services, in par-
ticular, for systemically highly compromised patients. (Source: Gomes et al. [31]) (Image 10).
3. “Omic” technologies applied in periodontal diseases
With advances in genomic (genes), transcriptomic (mRNA), proteomic (proteins), and metab-
olomic (metabolites) capabilities, an increased interest has emerged in the biologic system to 
define the complex regulatory networks that result in health or disease [32]. This implies a 
greater understanding of the data related to the etiopathogenesis of PD. These diseases are 
a multifactorial, highly complex disease involving some factors as host, environment, and 
microbiota. However, it is the host inflammatory response which may lead to the soft and 
hard tissue destruction. In severe diseases, this can lead to tooth loss [33].The host response 
to the infections draws upon the innate, inflammatory, and adaptive immune systems which 
provide an appropriate response to the aggressive microorganisms. In some individuals and 
with some bacteria, this phenomenon will be an innate-only response, others will need to 
invoke the inflammatory response, and yet others will require the adaptive immune response 
(cellular, humoral, or both) in order to reduce the microbial activities [33, 34].
Although much of what Page and Schroeder proposed in 1976 has stood the test of time, 
advances in the fields of basic and periodontal immunology need a reassessment of their work, 
as well as their integration with emerging new concepts [35]. Major advances have been made 
regarding the cellular and molecular mechanisms underlying the induction, regulation, and 
effector functions of immune and inflammatory responses. Likewise, Kornman [36] described 
a new look of the PD pathogenesis when he reported the specific bacteria and immunoinflam-
matory mechanisms related to innate differences among individuals and changes in environ-
mental factors. This fact may accelerate or attenuate these biochemical changes [37].
With emerging genomic, proteomic, and metabolomic data and tools of biology systems for 
interpreting data, it is now possible to start describing the basic elements of a new model of 
pathogenesis [36]. Stunning new findings have begun to clarify several complexities of the 
host-pathogen interaction of PD, pointing to key roles for microbial dysboisis and immune 
imbalance in the pathogenesis of disease [34].
Regarding the genomic knowledge, inflammation, cellular infiltration, and expression of a 
complex array of cytokines, chemokines, and lipid mediators are key characteristics of PD. In 
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PD, the presence of elevated inflammatory cytokines, including tumor necrosis factor (TNF)-α, 
interleukin (IL)-1, IL-6, interferon (IFN)-γ, and IL-12, is considered a central force when coupled 
with cell activation and RANKL (receptor activator of nuclear factor kappa-Β ligand) activation 
in driving pathogen elicited bone loss [38, 39]. In addition to pro-inflammatory cytokines, an 
array of chemokines including IL-8 and monocyte chemotactic protein (MCP)-1 and others are 
frequently elevated in PD [40]. Some examples of this type of interaction are described in the lit-
erature, for example, studies that reported a positive association between polymorphism of the 
IL-1 and PD [41, 42]. In addition, the presence of antiinflammatory and regulatory cytokines, 
such as transforming growth factor-beta (TGF-β), IL-10 and IL-4, has been reported [43, 44].
T lymphocyte cells (T cells) are well known as key regulating cells which orchestrate the host 
immune response. Considering the cells arise from the CD4+ population and are based on 
cytokine profiling, early studies showed that these cells were segregated into Th1 and Th2 
populations. Modern cytokine profiling and transcription factor analysis have led to a much 
more detailed classification of Th cells and the emergence of the Th17, Treg, TFH, Th9, and 
Th22 subsets [45, 46]. More advances have been recognized in what concerns the Toll-like 
receptors (TLRs) and TLR signaling; TIR-domain-containing adapter-inducing interferon-β 
(TRIF), interferon regulatory factors and type 1 interferon, and other pattern recognition 
receptors and PD, including scavenger receptors (SRs) and nucleotide-binding-oligomerization-
domain (NOD)-like receptors (NLRs) [34].
With a similar importance, the transcriptomics aspects are defined as gene expression pro-
file and when altered may influence the microbiota composition of periodontal pocket, as 
observed by Papapanou et al. [47]. In the same way, recent studies started to use proteomic 
techniques, promoting high resolution in the evaluation of proteins and molecular pathways 
involved in gingival inflammation [48, 49].
The gingival fluid composition of inflamed sites of patients with generalized aggressive 
periodontitis was evaluated by Bostanci et al. [50], demonstrating the proportion of enzymes 
associated with neutrophils, metalloproteinase of matrix-8, catepsin G, mieloperoxidase in 
addition to bacterial, viral, and yeast proteins that were increased in aggressive periodontitis 
when compared to healthy sites of individuals without periodontitis. Cystatin B and defen-
sins, defense proteins, were detected only in healthy individuals.
Proteins involved in immune response and antimicrobial function, such as α-amylases, cal-
granulin A, cystatin, C-lysozyme, and cathepsin G were regulated positively in the induction 
phase of gingivitis. In the resolution phase, several histones and neutrophilic proteins, includ-
ing cathepsin G, myeloperoxidase, and defensin-1 had their production decreased [49].
Concerning metabolomic aspects, among the earliest host-response molecules found in 
response to infection are lipid mediators [51]. Resolution of inflammation involves the pro-
duction of lipid mediators named immunoresolvents and includes the resolvins, protectins, 
lipoxins, and maresins [51, 52]. Functionally, resolvins limit inflammation in part through pre-
vention of neutrophil penetration, limiting inflammation at the local level, and promote tissue 
regeneration. The reduction of inflammation, through the use of resolvin-based approaches, 
may represent a novel strategy to potentially augment PD treatment approaches [53].
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New models in the next few years will be merely frameworks for integrating key knowledge 
as it becomes available from the “Omic” technologies for diagnosis, providing by identifying 
one or more biomarkers the detection of active disease, predict future progression, and evalu-
ate the response to periodontal therapy, thereby improving clinical management through 
early diagnosis and intervention, especially in case of patients with SHCN.
4. Alternative therapy for periodontics
As an alternative treatment to obtain the regeneration of the periodontium, the photobio-
modulation (PBM) and some bioactive materials may be indicated, once they strongly stimu-
late the periodontal tissue response, attenuate the inflammatory processes, and/or promote 
the microstructural reconstruction of the periodontium. However, in the indication of these 
therapies, PBM must be carefully studied, since it depends exclusively on the general and oral 
health status of each patient.
Concerning the patients with SHCN associated to immune system deficiency, the PBM, also 
known as low-level laser therapy (LLLT), has been largely used to promote therapeutic and 
biostimulating effects, such as analgesia, antiinflammatory action, angiogenesis, and mitogen-
esis [11]. Gomes et al. [11] assessed the impact of the GaAlAs diode laser on the periodontal 
tissues and investigated its effects on the alveolar bone remodeling process during orthodontic 
tooth movement in normoglycemic and diabetic rats. The authors demonstrated that the PMB 
strongly stimulated the alveolar bone remodeling and favored the continuous reorganization 
of the soft periodontal tissues, leading to the maintenance and the integrity of periodontal 
microstructures under orthodontic force, especially in uncontrolled diabetic rats (Figure 5).
Several bioactive materials have been used in the regenerative medicine, especially in patients with 
complex metabolic and cellular disorders. Among them, we highlighted homogenous demineral-
ized dentin matrix (HDDM), amniotic membrane (AM) used as a biological dressing, and differ-
ent types of platelet concentrates such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF). 
These biomaterials were applied in the craniomaxillofacial complex resulting in tissue regenera-
tion and microstructural reconstruction due to their effective inductive and conductive properties. 
The HDDM, PRP, and AM in implantation sites may initiate an inductive cascade as chemotaxis 
Figure 5. Low-level laser therapy applied on the periodontal tissues under orthodontic force (a) in a period of 21 days. 
Photomicrographs showing furcation region of the right mandibular first molar in diabetic rats: (b) diabetic rats with 
no laser irradiation displaying alveolar bone loss due to intense osteoclastic activity (square); and (c) diabetic rats with 
laser irradiation exhibiting suitable alveolar bone formation because of the intense osteoblastic activities (square) and the 
integrity of the periodontal ligament fibers (Source: Gomes et al. [11]).
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of progenitor cells, mitogenesis, angiogenesis, and differentiation into a wide variety of cells. The 
cell recruitment, division rate, and differentiation of cell lines are under the direct control of sev-
eral growth factors and stem cells which are found in these biomaterials [54–56].
In particular, the AM is a huge source for multipotent mesenchymal stem cells (MSCs) with 
the ability to differentiate into a wide variety of cells, such as chondroblasts, osteoblasts, adi-
pocytes and fibroblasts, myocytes, endothelial cells, neuronal cells, and hepatocytes, leading 
to formation of cartilage, bone, connective tissue, muscle, blood vessel, nerve, and liver tissue, 
respectively [56–58]. This membrane acts as a barrier, preventing the entry of pathogens and 
toxins, preserving the tissue structures, and, consequently, reducing the levels of local pro-
inflammatory cytokines [58, 59]. Thus, it could be largely used to selectively guide the tissue 
regeneration in the periodontium following destructive PD.
Regarding the second-generation platelet concentrate, the PRF clot forms a strong and dense 
natural fibrin mesh full of growth factors that can stimulate proliferation of PDL cells and 
osteoblasts; besides, it favors various cytokine entrapment and preserves the growth factors 
from proteolysis [60]. This concentrate is characterized by a high content of platelets and leu-
kocytes that release an array of growth factors such as platelet-derived growth factor (PDGF), 
transforming growth factor-beta 1 (TGF-β1), insulin-like growth factor (IGF), vascular endothe-
lial growth factor (VEGF), and the antiinflammatory cytokines [61].
Although the use of autologous platelet concentrates is not new to periodontics, cur-
rent researches are strongly encouraging the combination of platelet concentrates, such 
as PRP, PRF, and concentrated growth factors, with bone graft materials, membranes for 
guided tissue regeneration and MSCs to stimulate the periodontal regeneration. Most 
likely, this pool has synergistic effects, favoring the environment and the development 
of desirable periodontal tissues which were seriously compromised by the periodontal 
disease.
5. Considerations
Considering the high susceptibility to PD in people with SHCN, it is important that the dental 
practitioners know the different levels of disability complexity and how the undesirable envi-
ronment may impair the human and physical development, leading to temporary or perma-
nent disorders and/or diseases. Among the most common oral diseases, periodontal disease 
is an inflammatory condition which has been identified as a potential risk factor for systemic 
diseases. Therefore, it must be continuously controlled by the dentists to maintain the general 
health status of this individual.
In addition, other treatments for oral rehabilitation may be indicated when the periodontium 
is healthy, such as orthodontics, dental implants and/or the use of dental prostheses, contrib-
uting to the balance of the stomatognathic system, the preservation of the general health, a 
better quality of life, and, consequently, social inclusion.
In search of alternative therapies for this target public, the photobiomodulation for periodon-
tal tissue biostimulation and the reconstructive surgeries using bioactive materials may be 
recommended in order to favor the periodontal regeneration, to protect the periodontium 
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under daily actions of physicochemical agents and psychic conditions, and to restore lost 
periodontal microstructures.
Despite the entire scientific and technological development for people with SHCN, we may pre-
sume that the major challenges for health multiprofessionals are to promote the best transdisci-
plinary practices in oral healthcare on dental services and hospitals due to the high complexity 
of disabilities, conditions, disorders and diseases of these individuals; to perform people man-
agement focusing on the good interpersonal relationship among the health multiprofessionals, 
patient, family and caregivers; and to combat the several environmental and social factors that 
may strongly affect the decision-making power of the patient to carry out a satisfactory self-care.
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